| Literature DB >> 29891812 |
Prashamsa Koirala1, Su Hui Seong2, Yajuan Zhou3, Srijan Shrestha4, Hyun Ah Jung5, Jae Sue Choi6.
Abstract
Kuwanon G (KG) and benzofuran flavonoids such as mulberrofuran G (MG) and albanol B (AB) isolated from Morus sp. are reported to exhibit anti-Alzheimer’s disease, anti-inflammatory, fungicidal, anti-cancer, anti-bacterial, and anti-tyrosinase properties. We investigated the inhibition of mono- and diphenolase activity of mushroom tyrosinase by KG, MG, and AB. KG and MG displayed acceptable inhibition activity compared to kojic acid. AB did not show any activity up to 350 µM. MG displayed six-fold higher inhibition of l-tyrosine oxidation (IC50 = 6.35 ± 0.45 µM) compared to kojic acid (IC50 = 36.0 µM). Kinetic studies revealed that KG and MG inhibited monophenolase activity of tyrosinase in a competitive manner. Docking simulations of KG and MG demonstrated favorable binding energies with amino acid residues of the active sites of tyrosinase. Our investigation of the structure-activity relationship of the fused benzofuran flavonoids (MG vs. AB) implicated the methyl cyclohexene ring moiety in tyrosinase inhibition. The enzyme substrate and relative structural analyses demonstrated that KG and MG from Morus sp. could be useful natural tyrosinase inhibitors in foods or cosmetics.Entities:
Keywords: Morus species; albanol B; kuwanon G; mulberrofuran G; mushroom tyrosinase; structure-activity relationship
Mesh:
Substances:
Year: 2018 PMID: 29891812 PMCID: PMC6099663 DOI: 10.3390/molecules23061413
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Structure of compounds from Morus species and structural moieties explaining structure-activity relationship.
Inhibitory activities of the compounds isolated from the root bark of Morus alba on mushroom tyrosinase.
| Compounds | IC50 (μM) Value a | Inhibition Mode b | Inhibition Constant ( | |
|---|---|---|---|---|
| Kuwanon G | 67.6 ± 2.11 | 44.0 ± 3.73 | Competitive | 18.7 |
| Mulberrofuran G | 6.35 ± 0.45 | 105.6 ± 1.85 | Competitive | 5.19 |
| 1-Methyl-1-cyclohexene | >1000 | >1000 | NT e | NT |
| Albanol B | >350 | >350 | NT | NT |
| Kojic acid d | 36.0 ± 0.88 | 79.0 ± 0.06 | NT | NT |
a The 50% inhibition concentration (μM) is calculated from a log-dose inhibition curve and expressed as the mean ± SEM of triplicate experiments. b Determined by Lineweaver–Burk plot. c Determined by Dixon plot. d Positive control. e Not tested. -DOPA: l-3,4-dihydroxyphenylalanine.
Figure 2Concentration-dependent inhibition of kuwanon G, mulberrofuran G, and kojic acid on the activity of tyrosinase for the catalysis of -tyrosine at 25 °C.
Figure 3Dixon plots and Lineweaver–Burk plots for mushroom tyrosinase inhibition of mulberrofuran G.
Figure 4Dixon plots and Lineweaver–Burk plots for mushroom tyrosinase inhibition of kuwanon G.
Figure 5Inhibition mode of kuwanon G (A), mulberrofuran G (B), and albanol B (C) for the oxy-form mushroom tyrosinase catalytic site with -tyrosine (blue stick). Two copper ions and peroxide ions are represented as orange and red spheres, respectively. Tested inhibitors are represented in green stick. 2D diagram of tyrosinase inhibition by kuwanon G (D), mulberrofuran G (E), and albanol B (F).
Molecular interaction of oxy-form mushroom tyrosinase active site with three compounds as well as positive controls.
| Compounds | Binding Energy (Kcal/mol) | H-Bond Interaction | Van der Waals Interaction | Hydrophobic Interaction | Others |
|---|---|---|---|---|---|
| Kuwanon G | −6.95 | Per402, Val283, His263, Gly281, Ser282 | Cu400, Cu401 | Pi-sigma: Val283 | Pi-Cation: Arg268 |
| Mulberrofuran G | −7.60 | Per402, Arg268, Val283 | Cu400, Cu401 | Pi-sigma: Val283 | Pi-Sulfur: Met257 |
| Albanol B | −7.28 | Cys83, His244, Met257, Thr261 | ‒ | Pi-Sigma: His85 | ‒ |
| −6.31 | His244, Asn260, Met280, Glu256 (Salt-bridge) | Per402, Cu400, Cu401 | Pi-Sigma: Val283 | ‒ | |
| Kojic acid b | −5.5 | Met280 | Cu400, Cu401 | Pi-Sigma: Val283 | |
| Cinnamic acid b,c | −6.20 | Gln307, Asp312, Glu356 | Tyr314 | Pi-Pi Stacked: Trp358 | ‒ |
a Reported competitive ligand. b Reported competitive type inhibitor.b Reported mixed type inhibitor. c Interaction of cinnamic acid to allosteric site, while troplone (co-ligand of 2Y9X) is sited in catalytic pocket.